GITR Ligation Improves Anti-PD1-Mediated Restoration of Human MMR-Proficient Colorectal Carcinoma Tumor-Derived T Cells-Reference-Cited by-同舟云学术

GITR Ligation Improves Anti-PD1-Mediated Restoration of Human MMR-Proficient Colorectal Carcinoma Tumor-Derived T Cells

Published:2023 Issue:1 Volume:15 Page:77-97
ISSN:2352-345X
Container-title:Cellular and Molecular Gastroenterology and Hepatology
language:en
Short-container-title:Cellular and Molecular Gastroenterology and Hepatology

Author:

Rakké Yannick S.,Campos Carrascosa Lucia,van Beek Adriaan A.,de Ruiter Valeska,van Gemerden Rachelle S.,Doukas Michail,Doornebosch Pascal G.,Vermaas Maarten,ter Borg Susan,van der Harst Erwin,Coene Peter Paul L.O.,Kliffen Mike,Grünhagen Dirk J.,Verhoef Cornelis,IJzermans Jan N.M.,Kwekkeboom Jaap,Sprengers Dave

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference48 articles.

1. Colorectal cancer;Dekker;Lancet,2019

2. The consensus molecular subtypes of colorectal cancer;Guinney;Nat Med,2015

3. Discovering dominant tumor immune archetypes in a pan-cancer census;Combes;Cell,2022

4. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome;Galon;Science,2006

5. PD1 blockade in tumors with mismatch-repair deficiency;Le;N Engl J Med,2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Locoregional therapies combined with immune checkpoint inhibitors for liver metastases;Cancer Cell International;2024-08-31

2. Mismatch repair-proficient tumor footprints in the sands of immune desert: mechanistic constraints and precision platforms;Frontiers in Immunology;2024-07-19

3. The role of CD8+ T-cells in colorectal cancer immunotherapy;Heliyon;2024-06

4. Engaging stimulatory immune checkpoint interactions in the tumour immune microenvironment of primary liver cancers – how to push the gas after having released the brake;Frontiers in Immunology;2024-02-19

5. Enhancing personalized immune checkpoint therapy by immune archetyping and pharmacological targeting;Pharmacological Research;2023-10